Patent · US Active

Nanoformulation of spriooxindole and methods for treating hepatocellular carcinoma

US11944604B1 · kind B1 · utility

0Cited by

8References

7Claims

0Family size

Assignee

KING SAUD UNIVERSITY · SA

Inventors

Assem Barakat · Riyadh, SA
Fardous F. El-Senduny · Riyadh, SA
Mohammad Shahidul Islam · Riyadh, SA
Abdullah Mohammed Al Majid · Riyadh, SA
Yaseen Ali Mosa Mohamed Elshaier · Riyadh, SA
Eman Ahmed Ibrahim Mazyed · Riyadh, SA
Farid A. Badria · Riyadh, SA

Key dates

Filing date	Mar 10, 2023
Grant date	Apr 2, 2024
Priority date	—
Expiry date	Mar 10, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A spirooxindole nanoformulation includes a proniosome loaded with a spirooxindole derivative. In an embodiment, the spirooxindole derivative comprises (Compound 4d)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.